Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$5.31 - $11.98 $14,676 - $33,112
-2,764 Reduced 12.01%
20,247 $146,000
Q4 2022

Feb 14, 2023

BUY
$6.86 - $10.65 $16,717 - $25,954
2,437 Added 11.85%
23,011 $214,000
Q3 2022

Feb 14, 2023

SELL
$9.37 - $19.88 $18,018 - $38,229
-1,923 Reduced 8.55%
20,574 $211,000
Q3 2022

Nov 14, 2022

SELL
$9.37 - $19.88 $18,018 - $38,229
-1,923 Reduced 8.55%
20,574 $203,000
Q2 2022

Feb 14, 2023

SELL
$16.01 - $27.99 $6,804 - $11,895
-425 Reduced 1.85%
22,497 $360,000
Q2 2022

Aug 15, 2022

SELL
$16.01 - $27.99 $6,804 - $11,895
-425 Reduced 1.85%
22,497 $360,000
Q1 2022

Feb 14, 2023

BUY
$22.47 - $45.75 $52,759 - $107,421
2,348 Added 11.41%
22,922 $523,000
Q1 2022

May 13, 2022

BUY
$22.47 - $45.75 $515,057 - $1.05 Million
22,922 New
22,922 $523,000

Others Institutions Holding ZIMV

About ZimVie Inc.


  • Ticker ZIMV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,084,000
  • Market Cap $361M
  • Description
  • ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bo...
More about ZIMV
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.